Jumanji has entertained audiences with its high-stakes jungle thrills since its 1995 release. While the film has spawned a ...

Jamie Lee Curtis and Danny DeVito support director James L. Brooks at his Walk of Fame star ceremony in Hollywood, California ...

HBO has some incredible thriller shows that would wholly appeal to genre fans, but even with A-list casts, these series fell ...

Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them just a few years in. Eli Lilly is rewriting the rules of pharma. Not only did ...

IMDb.com, Inc. n'assume aucune responsabilité quant au contenu ou à l'exactitude des articles de presse, des tweets ou des billets de blogue susmentionnés. Ce contenu est publié uniquement dans le but ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eli Lilly achieved a $1 trillion market cap, a healthcare first, ...

Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

The booming market for weight-loss drugs has propelled Eli Lilly LLY1.16%increase; green up pointing triangle to become the first pharmaceutical company to hit $1 trillion in market capitalization, ...

The 150-year-old drugmaker is the first company in health care to hit the milestone. By Rebecca Robbins Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, ...

Eli Lilly shares rose again Tuesday, their sixth increase in the past seven sessions. The drugmaker's market cap also closed at a record, $973.8 billion, as Lilly inched closer to the $1 trillion ...

Sen. Ruben Gallego (D-Ariz.) is asking for more information on Eli Lilly’s recently announced agreement with the Trump administration regarding the sale of its GLP-1 medication. In a letter to Lilly ...